ВИРУС-АССОЦИИРОВАННЫЙ ГЕПАТОЦЕЛЛЮЛЯРНЫЙ РАК ПЕЧЕНИ
Аннотация
В обзоре представлены эпидемиологические данные о распространении гепатоцеллюлярного рака печени (ГЦР) в разных странах мира и Республике Беларусь, которая относится к странам с низким распространением ГЦР. Основная информация содержит сведения о вариантах рака печени, ассоциированного с разными гепатотропными вирусами (HBV, HCV, HDV), патологический процесс при котором манифестирует в виде моно- или микст-вирусной инфекции. Рассматриваются механизмы трансформации инфекционного процесса в онкологический. Подчеркиваются значение фиброза и цирроза печени в развитии рака как конкурирующего заболевания, особенности морфологической картины в печени и влияние терапии на течение цирроза и гепатоцеллюлярного рака печени.Литература
Rous P. A transmissible avian neoplasm. (Sarcoma of the common fowl.). J Exp Med. 1910;12(5):696-705. https://doi.org/10.1084/jem.12.5.696.
Rous P. A Sarcoma of the fowl transmissible by an agent separable from the tumor cells. J Exp Med. 1911;13(4):397-411. https://doi.org/10.1084/jem.13.4.397.
Nobelevskaja premija po medicine 1966. Pejton Rous. Available from: http://nobeliat.ru/laureat.php?id=313 (Russian).
Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016;4(9):e609-e616. https://doi.org/10.1016/S2214-109X(16)30143-7.
Kuznetsov OE. Virusy i opuhol – aspekt opasnoj svjazi (virusno-geneticheskaja teorija vozniknovenija opuholej). Medicinskaja panorama. 2013;1:15-18. (Russian).
Lunn RM, Jahnke GD, Rabkin CS. Tumour virus epidemiology. Philos Trans R Soc Lond B Biol Sci. 2017;372(1732):20160266. https://doi.org/10.1098/rstb.2016.0266.
White MK, Pagano JS, Khalili K. Viruses and human cancers: a long road of discovery of molecular paradigms. Clin Microbiol Rev. 2014;27(3):463-481. https://doi.org/10.1128/CMR.00124-13.
Kit OI, Shaposhnikov AV. Gepatocelljuljarnyj rak: Klassifikacija metodov hirurgicheskogo lechenija [Hepatocellular carcinoma. Surgical management classifications]. Annaly hirurgicheskoj gepatologii. [Annals of HPB surgery] 2012;17(3):104-109. (Russian).
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. https://doi.org/10.3322/caac.21492.
Balogh J, Victor D, Asham EH, Burroughs SG, Boktour M, Saharia A, Li X, Ghobrial RM, Monsour HP Jr. Hepatocellular carcinoma: a review. J Hepatocell Carcinoma. 2016;3:41-53. https://doi.org/10.2147/JHC.S61146.
Mak LY, Cruz-Ramón V, Chinchilla-López P, Torres HA, LoConte NK, Rice JP, Foxhall LE, Sturgis EM, Merrill JK, Bailey HH, Méndez-Sánchez N, Yuen MF, Hwang JP. Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma. Am Soc Clin Oncol Educ Book. 2018;38:262-279. https://doi.org/10.1200/EDBK_200939.
World Health Organization; International Agency for Research on Cancer. All cancers Source: Globocan 2020. Available from: https://gco.iarc.fr/today/data/factsheets/cancers/39-All-cancers-fact-sheet.pdf.
Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42(5):1208-1236. https://doi.org/10.1002/hep.20933.
World Health Organization; International Agency for Research of Cancer. Liver. Source: Globocan 2020. Available from: https://gco.iarc.fr/today/data/factsheets/cancers/11-Liver-fact-sheet.pdf.
Gepatocelljuljarnyj rak (S22.0). In: Sukonko OG, Krasnyj SA, editors. Algoritmy diagnostiki i lechenija zlokachestvennyh novoobrazovanij. Minsk: RNPC onkologii i radiologii im NN. Aleksandrova; 2012. Ch. 13; p. 151-159. (Russian).
Tsyrkunov VM, Matsiyeuskaya NV, Prokopchik NI, Hilchenko EI, Rebeko IV, Cyrus TP. Jepidemiologicheskie i kliniko-morfologicheskie osobennosti gepatocelljuljarnogo raka v Respublike Belarus. Zhurnal Grodnenskogo gosudarstvennogo medicinskogo universiteta [Journal of the Grodno State Medical University]. 2007;1:148-152. (Russian).
World Health Organization; International Agency for Research of Cancer. Estimated age-standardized incidence rates (World) in 2020, all cancers, both sexes, all ages. Available from: https://gco.iarc.fr/today/online-analysis-map?v=2020.
Kaprin AD, Starinskij VV, Petrova GV, editors. Zlokachestvennye obrazovanija v Rossii v 2017 godu (zabolevaemost i smertnost). Moskva: MNIOI im. P.A. Gercena; 2018. 250 p. (Russian).
Maucort-Boulch D, de Martel C, Franceschi S, Plummer M. Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide. Int J Cancer. 2018;142(12):2471-2477. https://doi.org/10.1002/ijc.31280.
Ringelhan M, McKeating JA, Protzer U. Viral hepatitis and liver cancer. Philos Trans R Soc Lond B Biol Sci 2017;372(1732):20160274. https://doi.org/10.1098/rstb.2016.0274.
Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014;383(9930):1749-1761. https://doi.org/10.1016/S0140-6736(14)60121-5.
Omata M, Cheng AL, Kokudo N, Kudo M, Lee JM, Jia J, Tateishi R, Han KH, Chawla YK, Shiina S, Jafri W, Payawal DA, Ohki T, Ogasawara S, Chen PJ, Lesmana CRA, Lesmana LA, Gani RA, Obi S, Dokmeci AK, Sarin SK. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017;11(4):317-370. https://doi.org/10.1007/s12072-017-9799-9.
Prokopchik NI, Tsyrkunov VM. Klinicheskaja morfologija pecheni: zlokachestvennye opuholi [Clinical morphology of liver: malignant tumors]. Zhurnal Grodnenskogo gosudarstvennogo medicinskogo universiteta [Journal of the Grodno State Medical University]. 2018;16(1):57-68. https://doi.org/10.25298/2221-8785-2018-16-1-57-68 (Russian).
Tustumi F, Ernani L, Coelho FF, Bernardo WM, Junior SS, Kruger JAP, Fonseca GM, Jeismann VB, Cecconello I, Herman P. Preoperative strategies to improve resectability for hepatocellular carcinoma: a systematic review and meta-analysis. HPB (Oxford). 2018;20(12):1109-1118. https://doi.org/10.1016/j.hpb.2018.06.1798.
2.png)
